 Record Annual Revenue of 41 Million HACKENSACK, NJ ACCESSWIRE July 22, 2021 Champions Oncology, Inc. NASDAQ:CSBR, engaged in creating transformative technology solutions to be utilized in drug discovery and development, today announced its financial results for the year and fourth fiscal quarter ended April 30, 2021. Fourth Quarter and Fiscal Year 2021 Financial and Recent Business Highlights: Record annual revenue of 41.0 million, an increase of 28 year-over-year Developed in house computational target discovery expertise to discover novel therapeutic targets Continued expansion of our Lumin SaaS platform Ronnie Morris, CEO of Champions, commented, Our year was highlighted by new strategic initiatives that have the potential to be transformative for Champions. 